$178 Million is the total value of Founders Fund VII Management, LLC's 2 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABCL | New | ABCELLERA BIOLOGICS INC | $151,847,000 | – | 3,773,530 | +100.0% | 85.11% | – |
| CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $26,572,000 | – | 557,760 | +100.0% | 14.89% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ABCELLERA BIOLOGICS INC | 12 | Q3 2023 | 94.5% |
| COMPASS PATHWAYS PLC | 12 | Q3 2023 | 20.4% |
View Founders Fund VII Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Founders Fund VII Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.